[Does the treatment focused on controlling the activity of the underlying inflammatory disease and reducing the serum level of AA protein improve the prognosis of systemic amyloidosis?].
Barrio
V
V
Servicio de Nefrología, Hospital Infanta Sofia, Madrid, Spain.
Ortiz-Herbener
F
F